Publications relating parotid dose–volume characteristics to radiotherapy-induced salivary
toxicity were reviewed. Late salivary dysfunction has been correlated to the mean parotid …

Radiotherapy (RT) is used to treat approximately 80% of patients with cancer of the head
and neck. Despite enormous advances in RT planning and delivery, a significant number of …

A review of literature on the development of sensorineural hearing loss after high-dose
radiation therapy for head-and-neck tumors and stereotactic radiosurgery or fractionated …

The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) review summarizes
the currently available three-dimensional dose/volume/outcome data to update and …

Advances in dose–volume/outcome (or normal tissue complication probability, NTCP)
modeling since the seminal Emami paper from 1991 are reviewed. There has been some …

Purpose: To determine the relationships between the three-dimensional dose distributions
in parotid glands and their saliva production, and to find the doses and irradiated volumes …

Purpose: To assess long-term xerostomia in patients receiving parotid-sparing radiation
therapy (RT) for head-and-neck cancer, and to find the patient and therapy-related factors that …

PURPOSE: To identify the anatomic structures whose damage or malfunction cause late
dysphagia and aspiration after intensive chemotherapy and radiotherapy (RT) for head-and-…

Purpose To prospectively identify markers of response to therapy and outcome in an organ-sparing
trial for advanced oropharyngeal cancer. Patients and Methods Pretreatment …

Purpose: To objectively assess swallowing function after an intensive chemoradiation
regimen for locally advanced head-and-neck cancer and to assess the clinical implications of …